单胎妊娠阴道孕酮治疗中宫颈进行性缩短患者的宫颈环扎术
本研究为芝加哥伊利诺伊大学回顾性队列研究,纳入2013年1月至2016年12月单胎妊娠因偶然发现短宫颈(宫颈长度<20 mm)使用阴道孕酮、宫颈进行性缩短<10 mm并分娩的75例孕妇。结果显示环扎+孕酮组(36例)较单用孕酮组(39例)自发早产率显著降低(<37周44.1% vs 84.2%),分娩孕周显著延长(34周3天 vs 27周2天),新生儿结局改善;校正混杂因素后<37周自发早产相对风险0.11(95%CI 0.03-0.41,P<.001)。
要点
- 环扎+孕酮组<37周自发早产率44.1% vs 单用孕酮组84.2%,校正后RR 0.11(95%CI 0.03-0.41,P<.001)。
- 环扎+孕酮组平均分娩孕周34周3天 vs 单用孕酮组27周2天(P<.001)。
- 环扎+孕酮组新生儿ICU入住13例(36.1%)vs 单用孕酮组23例(65.7%),RR 0.55(95%CI 0.34-0.90,P=.018)。
核心结论
- 在宫颈进行性缩短<10 mm的单胎妊娠孕妇中,环扎联合阴道孕酮较单用阴道孕酮显著降低总体自发早产率、使妊娠潜伏期延长2倍,并降低总体新生儿发病率和死亡率。
研究设计与样本
- 芝加哥伊利诺伊大学回顾性队列研究,纳入2013年1月至2016年12月在该院分娩、单胎妊娠因偶然发现短宫颈(宫颈长度<20 mm)使用阴道孕酮、宫颈进行性缩短<10 mm的孕妇75例。
- 环扎与否基于个别医生的偏好;环扎+阴道孕酮组36例(48%),继续单用阴道孕酮组39例(52%)。
主要发现
- 两组基线特征、平均宫颈长度(5.06 vs 5.52 mm)及诊断极短宫颈时平均孕周(21.5 vs 21.3周)相似。
- 环扎+孕酮组平均分娩孕周显著大于单用孕酮组(34周3天 vs 27周2天;P<.001)。
- 环扎+孕酮组<37、35、32、28、24周自发早产率均显著低于单用孕酮组:44.1% vs 84.2%、38.2% vs 81.6%、23.5% vs 78.9%、14.7% vs 63.2%、11.8% vs 39.5%。
- 校正混杂因素后<37周自发早产仍显著(相对风险0.11;95%CI 0.03-0.41;P<.001);环扎+孕酮组平均妊娠潜伏期为14周。
- 环扎+孕酮组新生儿ICU入住13例(36.1%)vs 单用孕酮组23例(65.7%)(RR 0.55;95%CI 0.34-0.90;P=.018);呼吸窘迫综合征8例(22.2%)vs 17例(43.6%)(RR 0.59;95%CI 0.29-0.90;P=.027);环扎组新生儿坏死性小肠结肠炎或新生儿死亡风险亦显著更低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Premature cervical ripening plays a significant role in spontaneous preterm birth. Vaginal progesterone is the recommended treatment in singleton pregnancy with incidental short cervix. There is lack of evidence on whether it is beneficial to reinforce the cervix with cerclage when the cervical length becomes progressively shortened <10 mm while on vaginal progesterone. OBJECTIVE: Our aims are to determine whether cerclage with vaginal progesterone will: (1) reduce the overall spontaneous preterm birth rate, (2) prolong pregnancy latency, and (3) improve neonatal outcomes compared to vaginal progesterone alone. STUDY DESIGN: This was a retrospective cohort study at the University of Illinois at Chicago of all women with singleton pregnancy on vaginal progesterone for incidental short cervix, cervical length <20 mm. Only those with progressive cervical length shortening <10 mm who delivered at the University of Illinois at Chicago from January 2013 through December 2016 were included. The decision to perform cerclage was based on individual physician preference. Demographic data; information on serial cervical length status; medical, obstetric, and social history; cerclage vs no cerclage; and neonatal outcomes were compared. RESULTS: A total of 310 women with incidental short cervix on vaginal progesterone were identified, and of these, 75 had progressive shortening cervical length <10 mm and met inclusion criteria. Among the women with extremely shortened cervical length <10 mm, 36 women (48%) had cervical cerclage plus vaginal progesterone, and 39 women (52%) continued on vaginal progesterone alone. The baseline characteristics, mean cervical length (5.06 vs 5.52 mm), and mean gestational age at diagnosis of extreme short cervix (21.5 vs 21.3 weeks) were similar between women who received cerclage vs those who did not, respectively. The mean gestational age at delivery was significantly greater for those with cerclage (34 weeks and 3 days vs 27 weeks and 2 days; P < .001). The rate of spontaneous preterm birth at <37, 35, 32, 28, and 24 weeks were significantly lower in the cerclage group: 44.1% vs 84.2%, 38.2% vs 81.6%, 23.5% vs 78.9%, 14.7% vs 63.2%, and 11.8% vs 39.5%, respectively. The rate of spontaneous preterm birth <37 weeks remained significant after controlling for confounders (relative risk, 0.11; 95% confidence interval, 0.03-0.41; P < .001). The average pregnancy latency was 14 weeks in the cerclage combined with vaginal progesterone group compared to vaginal progesterone alone group. Neonatal intensive care unit admission and development of respiratory distress syndrome were significantly lower in the cerclage group compared to vaginal progesterone alone group: 13 (36.1%) vs 23 (65.7%) (relative risk, 0.55; 95% confidence interval, 0.34-0.90; P = .018) and 8 (22.2%) vs 17 (43.6%) (relative risk, 0.59; 95% confidence interval, 0.29-0.90; P = .027), respectively. Neonates of women with cerclage were also significantly less likely to develop necrotizing enterocolitis or experience neonatal death. CONCLUSION: Our study showed that cerclage plus vaginal progesterone in women with extremely shortened cervix significantly decreased overall spontaneous preterm birth rates, prolonged pregnancy latency by 2-fold, and decreased the overall neonatal morbidity and mortality.
引用
- Enakpene CA, DiGiovanni L, Jones TN, et al. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening. Am J Obstet Gynecol. 2018. PMID: 30017683. doi:10.1016/j.ajog.2018.06.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。